Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2711-2720 of 10669

Edit search filters
  1. Temozolomide and Irinotecan Hydrochloride with or without Bevacizumab in Treating Young Patients with Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors

    Rochester, MN

  2. Feasibility of Use of BariCare App in Pre-bariatric Surgery.

    Rochester, MN

  3. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome

    Rochester, MN

  4. Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A

    Rochester, MN

  5. New Methods to Diagnose Constrictive Pericarditis

    Rochester, MN

  6. Diaphragm Pacing System (DPS) in Participants with Amyotrophic Lateral Sclerosis (ALS)

    Jacksonville, FL

  7. A Study of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment for Patients with Stage IIIB/IV Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors

  9. A Study of AF-219 in Subjects with Idiopathic Pulmonary Fibrosis with Persistent Cough

    Rochester, MN

  10. A Study of the Performance, Effectiveness and Safety of a Vibrating Capsule Device in Aiding Constipated Individuals

    Rochester, MN

.

Mayo Clinic Footer